The Leukemia & Lymphoma Society

Company Bio

The Leukemia & Lymphoma Society (LLS) is the world's largest voluntary health agency dedicated to blood cancer. The LLS mission: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. LLS funds lifesaving blood cancer research around the world and provides free information and support services. Your donation is truly helping to save lives.

Geographic Focus

Woldwide

Featured Campaigns

Light The Night

40 percent of all cancer drugs approved by the FDA since 2000 were first approved to treat blood cancers, 60 percent of which of which were funded by LLS.

LLS provides free education & support for cancer patients and healthcare professionals, including vital support for finding & enrolling in clinical trials.

The Leukemia & Lymphoma Society (LLS) is the world's largest voluntary health agency dedicated to blood cancer.

LLS has more that 100,000 volunteers, who advocate for policies at the state and federal level to remove barriers to care for cancer patients.

LLS is the leading nonprofit that supports patients before, during and after their diagnosis and treatment.

More Info

LLS focusses on three pillars: Research, Patient Access, and Policy & Advocacy.

Research
LLS is at the forefront of the fight to cure cancer. Compared to other blood cancer nonprofits, LLS is the largest funder of cutting-edge research to advance cures. We have invested more than $1.2 billion in research. We are leaders in advancing breakthroughs in immunotherapy, genomics and personalized medicine. These revolutionary new treatments originally discovered through blood cancer research are now being tested in clinical trials for other cancers. This research saves lives

Patient Access
As the leading source of free blood cancer information, education and support for patients, survivors, families and healthcare professionals, LLS helps patients navigate their cancer treatment and ensures they have access to quality, affordable and coordinated care. Research will help us achieve an end to cancer. In the meantime, patients need help before, during and after their diagnosis and treatment.

Policy and Advocacy
Through our nationwide grassroots network of more than 100,000 volunteers, we advocate for policies at the state and federal level in a commitment to remove barriers to care for cancer patients. Our efforts have helped increase federal research funds, speed the review and approval process of new therapies and ensure patients are able to access lifesaving treatments. Many of the policies that we advocate for, at the state and federal levels, are universally beneficial for all cancer patients.